Logo image
miR34a: a master regulator in the pathogenesis of bronchopulmonary dysplasia
Journal article   Open access   Peer reviewed

miR34a: a master regulator in the pathogenesis of bronchopulmonary dysplasia

Pragnya Das, Mansoor Ali Syed, Dilip Shah and Vineet Bhandari
Cell Stress, v 2(2), pp 34-36
01 Feb 2018
PMID: 31225464
url
https://doi.org/10.15698/cst2018.02.124View
Published, Version of Record (VoR)CC BY V4.0 Open

Abstract

Cell Biology Life Sciences & Biomedicine Science & Technology
Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in infants with lifelong pulmonary and neurodevelopmental consequences. The pathogenesis of BPD is contributed by genetic and environmental factors; among the latter, a critical contributor is exposure of the developing lung to hyperoxia. We have recently reported (Nat Comm 8:1173) that hyperoxia exposure in our in vitro and in vivo modeling systems of hyperoxia-induced lung injury (HALT) and BPD leads to an upregulation of the microRNA (miR) 34a. Utilizing genetic loss- and gain- of function strategies, we show that miR34a inhibition ameliorates the pulmonary phenotype of BPD (including BPD-associated pulmonary hypertension), at least in part, via one of the downstream targets of miR34a, namely Angiopoietin1/Tie 2 signaling. In addition, we demonstrate translational clinical significance of our findings by showing increased miR34a and decreased Ang1 expression in 3 independent cohorts of human lung samples.

Metrics

12 Record Views
11 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Cell Biology
Logo image